WebAug 12, 2024 · CyPath™ Lung for Physician’s Use. Home / CyPath™ Lung for Physician’s Use. CyPath™ Lung for Physician’s Use. CyPath™ Lung Physician Portal. A Spirit of Excellence. Our passion is to selflessly serve our clients and their patients by providing excellent pathology services with Integrity and Ethical Behavior as our guiding values. WebMar 28, 2024 · CyPath ® Lung is marketed as a Laboratory Developed Test (LDT) by Precision Pathology Services. OncoSelect Therapeutics, LLC, a subsidiary of bioAffinity Technologies, is advancing its...
bioAffinity Technologies Validation Trial for Non-Invasive Lung …
WebApr 25, 2024 · BioAffinity has developed a non-invasive test called CyPath that helps improve the accuracy of lung cancer screening by analyzing a patient’s phlegm for cancer-related cells using flow cytometry... Web44927 George Washington Blvd., Suite 265, MSC 1173 Ashburn, VA 20147 flower shop kerrville tx
bioAffinity Technologies Announces Publication of Peer-Reviewed …
WebCyPath ® Lung is a non-invasive test that assists clinical decision-making in lung cancer patients whose low-dose computed tomography (LDCT) has demonstrated a suspicious finding. The test reveals the lung micro-environment by automated analysis of sputum using flow cytometry to characterize cell populations indicative of cancer in the lung. WebMay 25, 2024 · bioAffinity Technologies ( NASDAQ: BIAF) ( BIAFW) intends to raise $10 million from the sale of its common stock and warrants in an IPO, according to an amended registration statement. The company ... WebSep 14, 2024 · CyPath ® Lung is a flow cytometric test to aid in the diagnosis of lung cancer. Patients collect sputum samples non-invasively at home, a particular benefit during the COVID-19 pandemic. green bay packer crocs